{"id":"W4399320810","doi":"10.1016/j.euf.2024.05.007","title":"Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma","year":2024,"lang":"en","type":"article","venue":"European Urology Focus","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche; Roche","keywords":"Medicine; Atezolizumab; Urinary system; Oncology; Urology; Internal medicine; Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002774349,0.001259146,0.001816369,0.0003331784,0.0004688605,0.001426337,0.0004787139,0.0009141045,0.001500735],"category_scores_gemma":[0.002469868,0.0003837067,0.003390326,0.0004859808,0.0006988884,0.0007977407,0.0004100956,0.001555663,0.0004445156],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006476787,"about_ca_system_score_gemma":0.001078729,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00144479,"about_ca_topic_score_gemma":0.00411822,"domain_scores_codex":[0.9988926,0.0006262279,0.00006137359,0.0001647696,0.00008593066,0.0001691582],"domain_scores_gemma":[0.9984316,0.0005188439,0.0002594634,0.0002293087,0.0001714973,0.0003891895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7863064,0.004862496,0.108832,0.0006107239,0.00890152,0.0004684499,0.0004778551,0.001814328,0.01359242,0.0002031444,0.004857551,0.06907315],"study_design_scores_gemma":[0.2851201,0.1636733,0.5107908,0.0001716231,0.02093385,0.0007239262,0.0006181994,0.001525397,0.005526178,0.0006152689,0.01009863,0.0002027474],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918105,0.00259371,0.0003602499,0.0003896226,0.00008646863,0.0002232225,0.002190515,0.0000347819,0.002310929],"genre_scores_gemma":[0.9930562,0.000758416,0.0004845759,0.0006986599,0.0001298836,0.0001456858,0.003617545,0.00002687168,0.001082139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002774349,"threshold_uncertainty_score":0.01467228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02015626680701948,"score_gpt":0.2558305766856306,"score_spread":0.2356743098786111,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}